Literature DB >> 23031308

Histopathological and immunohistochemical assessment of invasive micropapillary mammary carcinoma in dogs: a retrospective study.

C O Gamba1, E J Dias, L G R Ribeiro, L C Campos, A Estrela-Lima, E Ferreira, G D Cassali.   

Abstract

Invasive micropapillary carcinoma (IMPC) of the mammary gland, despite its rare occurrence in humans and dogs, is an important neoplasm due to its aggressive behaviour. The aim of this study was to evaluate the clinicopathological and immunophenotypical characteristics of IMPC and to determine the overall survival of dogs with this tumour. Of the selected cases, the majority had >3 cm neoplasms (15/19, 78.95%) and lymph node metastases (16/16, 100%), but only two cases (2/9, 22.2%) had distant metastases. The IMPCs were classified as either pure (15/22, 68.18%) or mixed (7/22, 31.82%) types. There was a predominance of moderate histological grade tumours (16 grade II) and the average overall survival was 120 days. Positive immunohistochemical staining for epithelial membrane antigen and negative staining for CD-31, p63 and cytokeratin (CK) AE1AE3 in cystic formations confirmed the micropapillary nature of these neoplasms. A proportion of cases exhibited positive epithelial staining for p63 (4/20, 20%) and CK34βE12 (20/22, 90.9%). Most cases were positive for oestrogen (19/20, 95%) and progesterone (19/20, 95%) receptors, but lacked HER-2 (16/22, 72.72%) and epidermal growth factor receptor (15/22, 68.18%) over-expression. The mean proliferation index was 14.8%. The findings demonstrate that, similar to humans, canine IMPCs behave aggressively with high rates of metastasis to regional lymph nodes and short overall survival times.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23031308     DOI: 10.1016/j.tvjl.2012.08.022

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  7 in total

1.  Inner nuclear membrane localization of epidermal growth factor receptor (EGFR) in spontaneous canine model of invasive micropapillary carcinoma of the mammary gland.

Authors:  Michele A Rodrigues; Conrado O Gamba; Jerusa Araújo Quintão Arantes Faria; Ênio Ferreira; Alfredo M Goes; Dawidson A Gomes; Geovanni D Cassali
Journal:  Pathol Res Pract       Date:  2015-12-04       Impact factor: 3.250

2.  Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.

Authors:  M R de Araújo; L C Campos; E Ferreira; G D Cassali
Journal:  J Vet Intern Med       Date:  2015-06-30       Impact factor: 3.333

3.  Characterization of neoplastic cells outlining the cystic space of invasive micropapillary carcinoma of the canine mammary gland.

Authors:  Michele A Rodrigues; Andre L Caldeira-Brant; Dawidson A Gomes; Tatiany L Silveira; Hélio Chiarini-Garcia; Geovanni D Cassali
Journal:  BMC Vet Res       Date:  2021-03-24       Impact factor: 2.741

4.  Canine mammary cancer tumour behaviour and patient survival time are associated with collagen fibre characteristics.

Authors:  Ana P V Garcia; Luana A Reis; Fernanda C Nunes; Francis G J Longford; Jeremy G Frey; Ana M de Paula; Geovanni D Cassali
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

5.  COX-2 expression in mammary invasive micropapillary carcinoma is associated with prognostic factors and acts as a potential therapeutic target in comparative oncology.

Authors:  Thaynan Cunha Vieira; Evelyn Ane Oliveira; Bárbara Jaime Dos Santos; Fernanda Rezende Souza; Emerson Soares Veloso; Cristiana Buzelin Nunes; Helen Lima Del Puerto; Geovanni Dantas Cassali
Journal:  Front Vet Sci       Date:  2022-09-12

6.  Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.

Authors:  Judit Fazekas; Irene Fürdös; Josef Singer; Erika Jensen-Jarolim
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

7.  The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.

Authors:  Conrado de Oliveira Gamba; Karine Araújo Damasceno; Izabel Cristina Ferreira; Michele Angela Rodrigues; Dawidson Assis Gomes; Mariana Resende Alves; Rafael Malagoli Rocha; Alessandra Estrela Lima; Enio Ferreira; Geovanni Dantas Cassali
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.